FTC would review a new Merck/Sanofi-Aventis JV
Monday, 8 February 2010
Ron Knox
Drug makers Sanofi-Aventis and Merck are expected to reignite their animal-health joint venture in the coming weeks, exposing the companies to a fresh round of antitrust scrutiny by the US Federal Trade Commission.
PREMIUM Subscription required to view this article
This content can only be accessed by PREMIUM GCR subscribers.
A premium subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current and archived print & online content.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top